IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i3p1674-d740237.html
   My bibliography  Save this article

Factors Affecting Citizen Trust and Public Engagement Relating to the Generation and Use of Real-World Evidence in Healthcare

Author

Listed:
  • Denis Horgan

    (European Alliance for Personalised Medicine, 1040 Brussels, Belgium)

  • Bettina Borisch

    (Department of Histopathology, University of Geneva, 1202 Geneva, Switzerland)

  • Ivana Cattaneo

    (Novartis Farma SpA, 21040 Origgio, Italy)

  • Mark Caulfield

    (NIHR Barts Biomedical Research Centre, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK)

  • Arturo Chiti

    (Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy
    IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy)

  • Christine Chomienne

    (Cell Biology-Hematology Department, Université de Paris INSERM, 75010 Paris, France)

  • Amanda Cole

    (Office of Health Economics, London SW1E 6QT, UK)

  • Karen Facey

    (Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh EH8 9YL, UK)

  • Allan Hackshaw

    (Faculty of Medical Sciences, University College London, London W1T 4TJ, UK)

  • Minna Hendolin

    (Sitra—The Finnish Innovation Fund, 00180 Helsinki, Finland)

  • Nadia Georges

    (Exact Sciences, 1201 Geneva, Switzerland)

  • Dipak Kalra

    (Faculty of Medicine and Health Sciences, University of Ghent, 9000 Ghent, Belgium)

  • Birutė Tumienė

    (Vilnius University Hospital Santariskiu Klinikos, 08661 Vilnius, Lithuania)

  • Martina von Meyenn

    (F. Hoffmann-La Roche AG, 4070 Basel, Switzerland)

Abstract

The potential for the use of real-world data (RWD) to generate real-world evidence (RWE) that can inform clinical decision-making and health policy is increasingly recognized, albeit with hesitancy in some circles. If used appropriately, the rapidly expanding wealth of health data could improve healthcare research, delivery of care, and patient outcomes. However, this depends on two key factors: (1) building structures that increase the confidence and willingness of European Union (EU) citizens to permit the collection and use of their data, and (2) development of EU health policy to support and shape data collection infrastructures, methodologies, transmission, and use. The great potential for use of RWE in healthcare improvement merits careful exploration of the drivers of, and challenges preventing, efficient RWD curation. Literature-based research was performed to identify relevant themes and discussion topics for two sets of expert panels, organized by the European Alliance for Personalised Medicine. These expert panels discussed steps that would enable a gradual but steady growth in the quantity, quality, and beneficial deployment of RWE. Participants were selected to provide insight based on their professional medical, economic, patient, industry, or governmental experience. Here, we propose a framework that addresses public trust and access to data, cross-border governance, alignment of evidence frameworks, and demonstrable improvements in healthcare decisions. We also discuss key case studies that support these recommendations, in accordance with the discussions at the expert panels.

Suggested Citation

  • Denis Horgan & Bettina Borisch & Ivana Cattaneo & Mark Caulfield & Arturo Chiti & Christine Chomienne & Amanda Cole & Karen Facey & Allan Hackshaw & Minna Hendolin & Nadia Georges & Dipak Kalra & Biru, 2022. "Factors Affecting Citizen Trust and Public Engagement Relating to the Generation and Use of Real-World Evidence in Healthcare," IJERPH, MDPI, vol. 19(3), pages 1-18, February.
  • Handle: RePEc:gam:jijerp:v:19:y:2022:i:3:p:1674-:d:740237
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/3/1674/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/19/3/1674/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. D. L. Velden & L. R. Hoes & H. Wijngaart & J. M. Berge Henegouwen & E. Werkhoven & P. Roepman & R. L. Schilsky & W. W. J. Leng & A. D. R. Huitema & B. Nuijen & P. M. Nederlof & C. M. L. Herpen & D. J., 2019. "The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs," Nature, Nature, vol. 574(7776), pages 127-131, October.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Cambrosio, Alberto & Campbell, Jonah & Keating, Peter & Polk, Jessica B. & Aguilar-Mahecha, Adriana & Basik, Mark, 2022. "Healthcare policy by other means: Cancer clinical research as “oncopolicy”," Social Science & Medicine, Elsevier, vol. 292(C).
    2. Perla Pucci & Liam C. Lee & Miaojun Han & Jamie D. Matthews & Leila Jahangiri & Michaela Schlederer & Eleanor Manners & Annabel Sorby-Adams & Joshua Kaggie & Ricky M. Trigg & Christopher Steel & Lucy , 2024. "Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma," Nature Communications, Nature, vol. 15(1), pages 1-19, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:3:p:1674-:d:740237. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.